These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 15649737)

  • 1. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I
    Sleep Med Rev; 2005 Feb; 9(1):41-50. PubMed ID: 15649737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of benzodiazepine use in the treatment of insomnia.
    Holbrook AM; Crowther R; Lotter A; Cheng C; King D
    CMAJ; 2000 Jan; 162(2):225-33. PubMed ID: 10674059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
    Laakso ML; Lindblom N; Leinonen L; Kaski M
    Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
    Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
    J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
    van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W
    J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
    Bendz LM; Scates AC
    Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
    Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
    Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin as a hypnotic: con.
    van den Heuvel CJ; Ferguson SA; Macchi MM; Dawson D
    Sleep Med Rev; 2005 Feb; 9(1):71-80. PubMed ID: 15649741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
    Braam W; Didden R; Smits MG; Curfs LM
    J Child Neurol; 2008 Jun; 23(6):649-54. PubMed ID: 18539989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M; Niskanen L; Kangas AP; Koskinen T
    Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
    Hajak G; Rodenbeck A; Adler L; Huether G; Bandelow B; Herrendorf G; Staedt J; Rüther E
    Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melatonin--a natural hypnotic?].
    Saletu B
    Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
    Braam W; Smits MG; Didden R; Korzilius H; Van Geijlswijk IM; Curfs LM
    Dev Med Child Neurol; 2009 May; 51(5):340-9. PubMed ID: 19379289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin for sleep disturbances in Parkinson's disease.
    Dowling GA; Mastick J; Colling E; Carter JH; Singer CM; Aminoff MJ
    Sleep Med; 2005 Sep; 6(5):459-66. PubMed ID: 16084125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and sleep disorders associated with intellectual disability: a clinical review.
    Sajith SG; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):2-13. PubMed ID: 17181598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
    J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of melatonin to treat sleep disorder in adults with intellectual disabilities in community settings - the evaluation of three cases using actigraphy.
    Dodd A; Hare DJ; Arshad P
    J Intellect Disabil Res; 2008 Jun; 52(Pt 6):547-53. PubMed ID: 18444986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin treatment for circadian rhythm sleep disorders.
    Kamei Y; Hayakawa T; Urata J; Uchiyama M; Shibui K; Kim K; Kudo Y; Okawa M
    Psychiatry Clin Neurosci; 2000 Jun; 54(3):381-2. PubMed ID: 11186123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as a hypnotic: pro.
    Zhdanova IV
    Sleep Med Rev; 2005 Feb; 9(1):51-65. PubMed ID: 15649738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.